Orthostatic Cerebral Hypoperfusion Syndrome: When Your Brain Loses Blood Flow but Every Test Looks Normal

There's a particular kind of frustration that comes with being told you're fine when you know you're not. You stand up and your world narrows. Vision dims. Thoughts blur. You grip the counter and wait for it to pass. You wait months to get in with a specialist, finally get a tilt table test, and the report comes back: blood pressure stable, heart rate within normal limits. "We don't see anything wrong."

That phrase — "we don't see anything wrong" — usually means the test couldn't measure what was wrong. Not that nothing was happening. There's a syndrome that explains exactly this scenario, defined by a Harvard neurologist in 2016, replicated independently in Mexico (Gonzalez-Hermosillo et al., 2021), confirmed by brain imaging in Australia (Seeley et al., 2025), reviewed in a major 2025 paper in the Journal of the American Heart Association (Khan et al., 2025), and still almost completely unknown to the patients who have it.

It's called orthostatic cerebral hypoperfusion syndrome, or OCHOs.

What Is Orthostatic Cerebral Hypoperfusion Syndrome?

Orthostatic cerebral hypoperfusion syndrome (OCHOs): a condition where blood flow to the brain drops substantially during standing — while systemic blood pressure and heart rate remain completely normal. It was formally defined by Dr. Peter Novak at Brigham and Women's Hospital (Harvard Medical School) in a 2016 study published in Frontiers in Aging Neuroscience (Novak, 2016).

Normal blood pressure. Normal heart rate. Significant drop in brain blood flow. The problem is that every tilt table in the country measures the first two and ignores the third. Cerebral perfusion, the thing that's actually failing, isn't part of the standard test.

How Bad Is the Blood Flow Drop?

Novak's defining study compared 102 OCHOs patients against 102 age- and sex-matched healthy controls. Both groups started with identical cerebral blood flow velocity at rest — around 65 cm/s in the middle cerebral artery. Within 10 minutes of standing, the OCHOs group had lost an average of 24% of that flow. The controls barely moved. That's the gap between "your brain is getting what it needs" and "your brain is running on three-quarters of its fuel supply while you try to stand in a kitchen."

Data: Novak, Frontiers in Aging Neuroscience, 2016 — 102 OCHOs patients vs. 102 matched controls (p < 0.0001 for all CBFv measures)

Blood pressure and heart rate: virtually identical between groups. A clinician staring at those numbers on a tilt table monitor would call it a normal test. Send the patient home. And never know that this person's brain was losing perfusion the entire time, because the monitor on the wall doesn't measure what's happening above the neck.

What Causes the Brain Blood Flow to Drop?

The measurable finding from Novak's study was elevated cerebrovascular resistance. A second mechanism was proposed but not directly measured.

Cerebral vasoconstriction (measured). The arterioles in the brain tighten inappropriately when the person stands up. Blood pressure stays normal because the systemic vasculature is doing its job. But the brain's own vessels are clamping down when they shouldn't be. Novak measured cerebrovascular resistance at 1.92 mmHg/cm/s in OCHOs patients versus 1.52 in controls (p < 0.0001). Same blood pressure in, less blood flow out. The brain is restricting its own supply, and the mechanism is likely either sympathetic-mediated vasoconstriction or a loss of the parasympathetic vasodilation that normally keeps those arterioles open.

Failure of active venoconstriction. Novak proposed that impaired venous return could contribute to OCHOs, but he didn't measure cardiac output or venous dynamics directly. Stewart's group at New York Medical College did. In a subset of POTS patients, they showed that the problem isn't abnormally stretchy vessels — it's that the active sympathetic venoconstriction that should fire on standing is weak, slow, or absent. Everyone pools blood into the legs and abdomen when they stand up. That's just gravity. What's supposed to happen next is a rapid sympathetic signal that constricts the veins and pushes blood back toward the heart. In these patients, that signal doesn't arrive on time or with enough force. The vessels themselves are structurally normal — when Stewart's group gave them direct pharmacological stimulation, they constricted just fine. The reflex arc is the bottleneck, not the vessel wall.

This matters because it reframes the problem. The question isn't "are the veins too stretchy?" It's "why isn't the brain telling them to squeeze?" — which puts us right back to the central regulation failure we keep coming back to. Systrom's invasive cardiopulmonary exercise testing at Brigham and Women's confirmed this from the cardiac side: POTS patients show low right heart filling pressures and reduced stroke volume during exertion, not because the heart is weak, but because there isn't enough blood coming back to fill it. Give the heart volume and it pumps fine. The heart isn't the problem. The return is.

Researchers at New York Medical College demonstrated something critical here: the cerebral blood flow reduction during standing actually comes before the hyperventilation and tachycardia — not the other way around (Del Pozzi et al., Hypertension, 2014). The brain loses flow first. Then the body scrambles to compensate. That sequence matters because it means the CBF drop is the primary event, not a downstream consequence of something else going wrong.

Think about it this way. Checking arm blood pressure to assess brain blood flow is like checking water pressure at the faucet downstairs and assuming the shower on the second floor is fine. City pressure could be perfect. But if the pipes going upstairs are constricted, or the pump is weak, or there's a leak in the wall, the faucet downstairs has no idea. You have to go upstairs and check the shower.

Both mechanisms point to the same underlying issue: a failure of cerebral autoregulation — the brain's ability to maintain its own blood supply regardless of what's happening systemically. Normally, the brain protects its flow across a wide range of blood pressures and positions. In OCHOs, that protection has broken down. The systemic numbers stay fine. The brain doesn't have a pain receptor for low blood flow — you don't feel the drop directly. You feel the consequences: the fog, the dizziness, the sense that your brain just checked out.

How OCHOs Differs from POTS and Orthostatic Hypotension

When a patient says "I get dizzy when I stand up," the clinician is trained to check two things: does the blood pressure drop (orthostatic hypotension) or does the heart rate jump (POTS)? If neither shows up, the workup usually stops. OCHOs is a third category that's been sitting in the blind spot between the other two the entire time.

In Novak's data, OCHOs patients actually had a larger average cerebral blood flow drop (24%) than POTS patients (~19%). And they have a worse diagnostic outlook, because at least POTS shows something on a standard tilt test. OCHOs shows nothing. The tilt lab printout looks clean. The patient goes home with no answer and, often, a suggestion to see a psychiatrist.

How Common Is This?

More common than most physicians realize. In Novak's original screening of 1,279 patients referred for unexplained orthostatic dizziness, 8% met criteria for OCHOs (Novak, 2016). A second study of 744 patients found 13% had OCHOs — and not a single one had been previously diagnosed (Novak, Neuroscience Journal, 2016). Zero out of 97.

A 2025 review in the Journal of the American Heart Association went further. Khan and colleagues analyzed data across multiple studies and found that 58% of orthostatic intolerance participants had normal heart rate and blood pressure while experiencing orthostatic symptoms (Khan et al., JAHA, 2025). Standard tilt testing would have cleared every one of them as "normal."

In ME/CFS populations, the numbers are even more striking. A Dutch study of 429 ME/CFS patients found that 82% of those with normal heart rate and blood pressure responses still had abnormal cerebral blood flow reductions on tilt (van Campen et al., Clinical Neurophysiology Practice, 2020). Even at a mild 20-degree tilt angle, severe ME/CFS patients showed significant CBF drops (van Campen et al., Healthcare, 2020). That's not a fringe finding. That's the majority of a patient population falling through a diagnostic gap.

What Does OCHOs Feel Like?

If you've got this, you already know what it feels like. But here are the numbers from Novak's cohort:

Data: Novak, Frontiers in Aging Neuroscience, 2016

88% dizziness makes sense when the brain is losing that much fuel on standing. The 23% anxiety number is the one I want to flag. One in four of these patients had been given an anxiety diagnosis. And look — were they anxious? Yeah, probably. Your brain intermittently loses blood flow every time you stand up and nobody can tell you why. That would make anyone anxious. But the anxiety didn't cause the blood flow drop. The blood flow drop created the conditions for the anxiety. Get those confused and you end up treating the wrong thing.

Where OCHOs Fits in the Bigger Picture

After defining OCHOs, Novak went on to characterize a subset he called hypocapnic cerebral hypoperfusion (HYCH) — where the blood flow drop is specifically driven by low CO2 from subtle hyperventilation. That CO2 mechanism has been independently validated. A University of British Columbia study showed that inducing hypocapnia during orthostatic stress directly reduced CBF and worsened tolerance in healthy volunteers — and supplementing CO2 reversed both (Lewis et al., Journal of Physiology, 2014). In 2024, Novak's largest study confirmed that POTS and HYCH sit on a single spectrum of the same disorder (Novak et al., Frontiers in Neurology, 2024).

So how do these fit together? OCHOs is the broad umbrella. Anyone whose brain blood flow drops on standing without a blood pressure or heart rate explanation. HYCH is the subset where low CO2 is specifically driving the vasoconstriction. POTS sits adjacent: same cerebral hypoperfusion underneath, but with enough tachycardia to cross the diagnostic line.

The through-line across all of them: cerebral blood flow is the actual problem. Heart rate and blood pressure tell you how the body is compensating. They don't tell you whether the brain is getting what it needs. Khan and colleagues said it directly in their 2025 JAHA review: the field needs to move toward "incorporation of cerebral blood flow monitoring as the core diagnostic criteria" for orthostatic intolerance (Khan et al., 2025).

Why Cerebral Autoregulation Fails

Healthy brains protect their own blood supply. You can go from flat on your back to sprinting upright and the brain will adjust vessel diameter in real time to keep flow stable. That's cerebral autoregulation. When it fails, you get OCHOs. The question is why it fails.

There isn't one answer. The autoregulation system pulls from multiple inputs simultaneously, and a disruption in any of them can open a gap that the brain can't compensate for.

The vestibular system is a big one. It feeds gravitational and positional data to the brainstem, which uses that information to anticipate blood flow demand before you actually stand — not after. Yates and colleagues at the University of Pittsburgh called this the vestibulo-sympathetic reflex (Yates et al., Brain Research Bulletin, 2000), and a 2026 study from Seoul confirmed that POTS patients have abnormal vestibulo-sympathetic interaction and measurable otolith dysfunction (Woo et al., Clinical Autonomic Research, 2026). If the vestibular system isn't giving the brainstem accurate data, the anticipatory response is late or wrong.

Cervical proprioception is another. The neck feeds position data into the same brainstem circuits, and microneurography has shown that neck proprioceptive input directly modulates sympathetic nerve activity to the limbs (Bolton et al., Experimental Brain Research, 2014). We had a patient whose entire OCHOs pattern traced to corrupted proprioceptive data from the upper cervical spine. Arm blood pressure was textbook. Heart rate was textbook. But every time she stood up, her brainstem was getting bad position information and couldn't coordinate the cerebrovascular response in time. We fixed the cervical input. The autoregulation came back. TCD proved it.

Then there's the vessel wall itself. The cerebral arterioles have their own autoregulatory reflex built into the endothelium. When blood pressure rises, the vessel wall senses the stretch and constricts to protect the brain from overperfusion. When pressure drops, the endothelium relaxes and dilates to maintain flow. This is called the myogenic response, and it operates locally, independent of any signal from the brainstem. It's the brain's last line of defense for keeping its own blood supply stable.

When the endothelium is damaged, that reflex degrades. The vessel can't sense pressure changes as accurately, and it can't respond as quickly or proportionally. Post-COVID and post-viral vascular inflammation can impair exactly this mechanism (Wirth & Lohn, Medicina, 2022). The brainstem might be sending all the right signals. The baroreceptors might be firing correctly. But if the vessel wall can't execute the response, the autoregulation fails at the end effector. Neurovascular coupling, the brain's ability to match blood delivery to local metabolic demand in real time, depends on this same endothelial machinery. Damage it, and even perfect upstream signaling can't produce the right vascular response.

Concussions impair brainstem autonomic coordination directly. Post-viral insults damage small nerve fibers feeding baroreceptors. Any of these can produce cerebral hypoperfusion while leaving the arm cuff and heart rate monitor looking completely clean. The peripheral sympathetic response is intact. Cardiac vagal tone is intact. The only thing broken is the brain-level regulation that nobody is measuring.

The Diagnostic Problem

Most autonomic labs in the country cannot diagnose OCHOs. It's not a knowledge problem. It's an equipment problem. A standard tilt setup has an arm blood pressure cuff and a heart rate monitor. Maybe a respiratory belt or skin conductance. That's the whole toolkit. Transcranial Doppler? Almost nobody has it running during tilt.

Without transcranial Doppler during tilt, OCHOs is invisible. The blood pressure is normal. The heart rate is normal. The tilt table printout looks like a healthy person. The report says "normal autonomic function" and the patient gets referred for vestibular therapy, or CBT for health anxiety, or nothing at all. It's worth noting that the European Federation of Autonomic Societies already recommends provocative cardiovascular autonomic testing including cerebral blood flow monitoring (Thijs et al., Clinical Autonomic Research, 2021). The tools and the consensus exist. Most labs just haven't adopted them.

In Novak's second study, 97 out of 97 OCHOs patients had never been diagnosed. Every single one had symptoms severe enough to get referred for autonomic testing. They went through the system. Got the tilt. Got the "everything looks normal" report. And went home with a problem that was there the entire time, sitting in the data nobody collected.

What Actually Needs to Happen

So if you've been through a tilt and told everything was normal, but you know it's not, the next step is getting someone to measure what the standard test doesn't. Transcranial Doppler during a controlled tilt. Watching cerebral blood flow velocity change in real time as you go from supine to upright.

We pair that with capnography for CO2, oculomotor assessment, vestibular evaluation, and comprehensive autonomic testing. Because knowing that cerebral blood flow drops is only half the answer. You need to know why — vasoconstriction? Venous pooling? Hypocapnia? Endothelial damage? Impaired autoregulation? Some combination? Each one has a different treatment path, and lumping them together is how people end up on the same generic protocol that doesn't work.

Treatment goes after the mechanism driving the autoregulation failure. Not the dizziness. Not the fatigue. The actual reason the brain's blood supply isn't being maintained.

Where the regulation breaks down determines what we target:

• Impaired baroreceptor sensitivity. Graded postural challenges that retrain the pressure-sensing reflex arc. The baroreceptors need to relearn how to detect and respond to position changes accurately.
• Corrupted vestibular input. Vestibular rehabilitation to clean up the data the brainstem relies on for anticipatory blood flow adjustments. Your brainstem needs to know you're about to stand before gravity pulls the blood down. Vestibular input is how it knows.
• Bad cervical proprioceptive data. Neck-to-brainstem signal quality work. The cervical spine directly shapes the autonomic postural response. If the input is garbage, the output will be too.
• Hypocapnia-driven vasoconstriction. Central respiratory integration, not volitional breathing coaching. We recalibrate the brainstem circuits that control respiratory patterning so CO2 stabilizes on its own. (More on this in our HYCH article.)
• Endothelial dysfunction / impaired cerebral autoregulation. When the blood vessel lining itself is damaged (common post-COVID, post-viral), the vessels can't dilate or constrict the way the brain is asking them to. This requires a different approach: supporting vascular health, reducing neuroinflammation, and progressively reloading the autoregulatory system so it can rebuild capacity within the constraints of the damaged endothelium.

We track everything with TCD before and after. Subjective improvement matters, but it fluctuates. The Doppler doesn't. If the flow improves, we know we found the right lever. If it doesn't, we adjust. That's the difference between a treatment strategy and a guess.

Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Medication decisions should be made with your prescribing physician.

← Back to Blog